Microencapsulation for Enhanced Bioavailability of Fish Oil - Long Term Ingestion Study

Not Applicable

Active, not recruiting

• Conditions: Bioavailabilty of microencapsulated omega-3 oil as a dietary supplement; Diet and Nutrition - Other diet and nutrition disorders

• Registration Number: ACTRN12611000046909
• Lead Sponsor: CSIRO Preventative Health Flagship

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-01-13
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

(1) Male and Females aged between 18-70 years
(2) Normal dietary habits (no medically prescribed diet, no slimming diet, and no vegan or macrobiotic diet).
(3) Body Mass Index >18 kg/m^2 < 35kg/m^2 (calculation: Body Mass Index = weight in kg / height^2 in m^2).
(4) Apparently healthy: no reported current or previous metabolic diseases, gastrointestinal disorders, renal or cardiovascular disease.
(5) Person having given their specific consent in writing.

Exclusion Criteria

(1) Regular use of supplements containing omega-3 essential fatty acids must have ceased 2 months prior to the start of the study.
(2) Current relevant medical treatment (subject to judgement of the investigator).
(3) High alcohol consumption (>21 standard drinks/week)
(4) Reported participation in another biomedical trial 3 months before the start of the study or during the study.
(5) Food allergies or intolerances (dairy, lactose, peanuts, shellfish, etc…).
(6) Recent history (within 12 months) of substance abuse including alcohol abuse.

Study & Design

• Study Type: Interventional
• Study Design: Not specified